Medical industry and TMT (ie digital new media, Technology, Media, Telecom) and by virtue of its broad market prospects increasingly favored by venture capital organizations, over the weekend at the "2011 Halter Financial Summit", the participating venture capital industry executives talk about investment strategy in 2012 have shown the development of these two industry optimistic about the prospects.
Major U.S. venture capital fund KPCB (KPCB) partner of China, Huang Rui Jin pointed out, KPCB investment targets in the choice of the most valued in the relevant areas of its business model is a breakthrough. Based on this, whether it is China or the U.S. market, KPCB focuses on three areas: TMT, green technology and medical industries. As for the investment strategy. Huang Rui Jin believes that the invested enterprise, pattern, of course, is the venture capital product focus, but more from the perspective of market needs analysis to determine. "In the healthcare field, if the leading companies on the market, so whether it is early, mid or late we are willing to put money into it." Huang Rui Jin for example, said.
Gold Stone, vice president of Mi Jie said, Gold Stone focuses on the growth of the invested enterprise, "now I happened to be concerned about the health and medical fields." He also stressed that although not a long term investment and operation of stone, but the summary of past cases, the company For the pursuit of technology assets is very strong, in this context, the fund manager s task is related to in-house technology assets can do for effective assessment. For example, IT, health industry, bio-pharmaceutical industry contain specific, subtle, in-depth technical details, and details of the assessment capabilities of these technologies, often determines whether a given fund s key investment decisions.
Kai Liu Chiba investment partners also expressed a similar view. In her view, in people s clothing, food, shelter, basic conditions are met, the consumer will upgrade the main driver of future economic development. "Our fund s investment focus primarily in TMT, healthcare and other areas in the future, we hope this is a class of investment company that is able to put some of the leading scientific and technology to China, and China s future consumption and thus have more upgrades a good combination. "